Author:
Tang Shang-jun,Chen Li-kun,Wang Fang,Zhang Yun-kai,Huang Zhen-cong,To Kenneth Kin Wah,Wang Xiao-kun,Talele Tanaji T.,Chen Zhe-sheng,Chen Wei-qiang,Fu Li-wu
Subject
Pharmacology,Biochemistry
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer CellsviaStrong P-gp Inhibition;Anticancer Research;2023-02-28
2. Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity;International Journal of Molecular Sciences;2022-11-09
3. Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance;Anticancer Research;2022-04-30
4. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells;International Journal of Molecular Sciences;2022-04-21
5. CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10);Biochemical Pharmacology;2021-08